Atlas Trials

Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease

Clinical trial NCT01835496 · COMPLETED

Trial details

NCT number
NCT01835496
Sponsor
ApoPharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2013-05-01
Primary completion
2014-04-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.